Biostar Pharmaceuticals, Inc. Shareholders' Equity
Biostar Pharmaceuticals, Inc. had Shareholders' Equity of $36.15 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2017-11-20
- 2017-09-30: Stockholders' Equity Attributable to Parent $36.15M.
- 2017-06-30: Stockholders' Equity Attributable to Parent $35.49M.
- 2017-03-31: Stockholders' Equity Attributable to Parent $36.18M.
- 2016-12-31: Stockholders' Equity Attributable to Parent $36.88M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2017-09-30 | $36.15M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $35.49M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $36.18M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $36.88M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $34.03M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $35.76M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $43.95M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $44.27M 10-K · filed 2017-04-13 |
| 2015-09-30 | $67.95M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $72.34M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $72.56M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $72.34M 10-K · filed 2017-04-13 |
| 2014-09-30 | $69.44M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $67.39M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $65.55M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $62.77M 10-K · filed 2016-04-14 |
| 2013-09-30 | $61.74M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $60.35M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $58.78M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $57.77M 10-K · filed 2015-04-15 |
| 2012-09-30 | $64.12M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $69.46M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $78.87M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $76.40M 10-K · filed 2014-03-31 |
| 2011-09-30 | $75.22M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $69.96M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $60.50M 10-K · filed 2013-04-15 |
| 2009-12-31 | $40.92M 10-K · filed 2012-03-27 |